Skip to main content
Livermore
Livermore
ZHEN

Neuberger Berman Group LLC

SEC CIK
0001465109
Latest filing
Aug 13, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Neuberger Berman Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
267,855
Value
$21.0M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Neuberger Berman Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026267,855$21.0M<0.1%+240,442+877.1%AddedHolders
Q1 202627,413$1.77M<0.1%+477+1.8%AddedHolders
Q4 202526,936$1.81M<0.1%−838−3.0%ReducedHolders
Q3 202527,774$2.04M<0.1%−154,826−84.8%ReducedHolders
Q2 2025182,600$9.50M<0.1%−279,927−60.5%ReducedHolders
Q1 2025462,527$29.5M<0.1%+86,981+23.2%AddedHolders
Q4 2024375,546$18.0M<0.1%+89,464+31.3%AddedHolders
Q3 2024286,082$16.4M<0.1%+9,059+3.3%AddedHolders
Q2 2024277,023$14.5M<0.1%+17,342+6.7%AddedHolders
Q1 2024259,681$10.6M<0.1%+83,225+47.2%AddedHolders
Q4 2023176,456$6.52M<0.1%−7,997−4.3%ReducedHolders
Q3 2023184,453$7.05M<0.1%+1,542+0.8%AddedHolders
Q2 2023182,911$6.60M<0.1%+41,590+29.4%AddedHolders
Q1 2023141,321$5.40M<0.1%+6,909+5.1%AddedHolders
Q4 2022134,412$7.65M<0.1%−43,849−24.6%ReducedHolders
Q3 2022178,261$7.05M<0.1%+2,907+1.7%AddedHolders
Q2 2022175,354$7.72M<0.1%+9,079+5.5%AddedHolders
Q1 2022166,275$6.63M<0.1%+6,854+4.3%AddedHolders
Q4 2021159,421$6.35M<0.1%−438−0.3%ReducedHolders
Q3 2021159,859$6.42M<0.1%−71,203−30.8%ReducedHolders
Q2 2021231,062$10.5M<0.1%+17,907+8.4%AddedHolders
Q1 2021213,155$8.89M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.